Clinical Trials Browser

Phase 3 × Melanoma × peginterferon alfa-2a × Clear all

NCT00204529 2017-05-03

Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB

Phase 3 Completed

Melanoma